Acute Leukemia: Chemotherapy & Gut Dysbiosis

University of Minnesota
Completed Trials
  • Researchers tracked the microbial communities of patients undergoing intensive chemotherapy for Acute leukemia and monitored the impact on the diversity of the gut microbiome. Investigators followed two groups of patients, those completing their first induction of chemotherapy and those undergoing repeat therapy.
  • The study found "larger departures of microbial communities from the pre-chemotherapy baseline during repeat therapy compared to first induction."
  • Read the trial publication here.